Nuffield Department of Surgical Sciences, University of Oxford, Level 4, John Radcliffe Hospital, Oxford, United Kingdom; Department of Cellular Pathology, Oxford University Hospitals NHS FT, Oxford, United Kingdom.
International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France.
Mod Pathol. 2024 Jul;37(7):100515. doi: 10.1016/j.modpat.2024.100515. Epub 2024 May 17.
Evidence-based medicine (EBM) can be an unfamiliar territory for those working in tumor pathology research, and there is a great deal of uncertainty about how to undertake an EBM approach to planning and reporting histopathology-based studies. In this article, reviewed and endorsed by the Word Health Organization International Agency for Research on Cancer's International Collaboration for Cancer Classification and Research, we aim to help pathologists and researchers understand the basics of planning an evidence-based tumor pathology research study, as well as our recommendations on how to report the findings from these. We introduce some basic EBM concepts, a framework for research questions, and thoughts on study design and emphasize the concept of reporting standards. There are many study-specific reporting guidelines available, and we provide an overview of these. However, existing reporting guidelines perhaps do not always fit tumor pathology research papers, and hence, here, we collate the key reporting data set together into one generic checklist that we think will simplify the task for pathologists. The article aims to complement our recent hierarchy of evidence for tumor pathology and glossary of evidence (study) types in tumor pathology. Together, these articles should help any researcher get to grips with the basics of EBM for planning and publishing research in tumor pathology, as well as encourage an improved standard of the reports available to us all in the literature.
循证医学(EBM)对于从事肿瘤病理学研究的人来说可能是一个陌生的领域,对于如何采用循证医学方法来规划和报告基于组织病理学的研究,存在着很大的不确定性。在本文中,我们旨在帮助病理学家和研究人员了解规划基于循证的肿瘤病理学研究的基础知识,以及我们对如何报告这些研究结果的建议。我们介绍了一些基本的 EBM 概念、研究问题的框架以及关于研究设计的思路,并强调了报告标准的概念。有许多特定于研究的报告指南可用,我们对这些指南进行了概述。然而,现有的报告指南并不总是适合肿瘤病理学研究论文,因此,在这里,我们将关键的报告数据集汇集在一起,形成一个通用的检查表,我们认为这将简化病理学家的任务。本文旨在补充我们最近关于肿瘤病理学证据等级和肿瘤病理学证据(研究)类型词汇表的文章。这些文章应该有助于任何研究人员掌握在肿瘤病理学中规划和发表研究的循证医学基础知识,并鼓励提高我们在文献中可用的报告标准。